Hematology Home >
- Faculty
James P. Stevenson, M.D.Associate Professor of Clinical Medicine
Staff Physician
Department: Medicine
Contact information
Penn Presbyterian Medical Center,
103-A Medical Arts Building Philadelphia, PA 19104
Office: 215-662-9801
Education:
B.A. (English/Pre-Professional Studies) University of Notre Dame, 1988. M.D. Jefferson Medical College, 1992.
Post-Graduate Training
Intern in Medicine, University of Florida Hospitals, Gainesville, FL, 1992-1993. Resident in Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, 1993-1995. Fellowship, Hematology and Medical Oncology, Thomas Jefferson University, Kimmel Cancer Center, Philadelphia, PA, 1995-1998.
Certifications
Permanent linkNational Board of Medical Examiners, 1993. American Board of Internal Medicine, 1995. American Board of Internal Medicine - Medical Oncology, 1998. Selected PublicationsStevenson JP, Sun W, Rosen M, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, Chaplin D, Schnall M, O’Dwyer PJ. : Phase I trial of the antivascular agent Combretastatin A4 phosphate on a five-day schedule to patients with cancer: MRI evidence for altered tumor blood flow. J Clin Oncol. 21: 4428-4438, 2003.Flaherty KT, Stevenson JP, Hahn SM, Redlinger M, O’Dwyer PJ. : Phase I Combination Trial of Gemcitabine, Paclitaxel, and Carboplatin in Patients with Advanced Malignancy. Cancer Chemother Pharmacol 52: 217-222, 2003. Friedberg JS, Mick R, Stevenson JP, Zhu T, Busch TM, Shin D, Smith D, Culligan M, Dimofte A, Glatstein E, Hahn SM. : A phase II trial of pleural photodynamic therapy (PDT) and surgery for patients with non-small cell lung cancer (NSCLC) with pleural spread. J Clin Oncol 22: 2192-2201, 2003. Friedberg JS, Mick R, Stevenson J, Metz J, Zhu T, Buyske J, Sterman DH, Pass HI, Glatstein E, Hahn SM. : A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thoracic Surg 75: 952-9, 2003. Flaherty KT, Stevenson JP, Gallagher M, Giantonio B, Algazy KM, Karlin D, Sun W, Haller DG, O’Dwyer PJ. : Dose Escalation Study of Tezacitabine [(E)-2’-deoxy-2’-(fluoromethylene)cytidine] in Combination with Cisplatin in Patients with Advanced Cancer. Cancer 97: 1985-1990, 2003. Flaherty KT, Stevenson JP, Redlinger M, Algazy KM, Giantonio B, O’Dwyer PJ. : A Phase I, Dose Escalation Trial of ZD0473, a Novel Platinum Analogue, in Combination with Gemcitabine. Cancer 53: 404-408, 2004. Stevenson JP, Nho CW, Schick J, Johnson SW, Algazy K, Miller D, O’Dwyer PJ. : Phase II clinical/pharmacodynamic trial of the proteasome inhibitor PS-341 in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 22: 202, 2003. Bilenker JH, Stevenson JP, Rosen MA, Gallagher M, Flaherty KT, Algazy KM, Sun W, Schnall M, O’dwyer PJ. : Phase Ib trial of combretastatin A-4 phosphate (CA4P) in combination with carboplatin in patients with advanced cancer. Proc Am Soc Clin Oncol 22: 222, 2003.
|
